Coherus BioSciences
CHRS • NASDAQ
Coherus BioSciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Dennis Lanfear, with a market cap of $244.3M.
Market Cap$244.3M
Employees306.0
CEODennis Lanfear
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · in a monthQ1 2026
Financials
Coherus BioSciences FAQ
Common questions about Coherus BioSciences
Coherus BioSciences is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $14.4M.
Coherus BioSciences has approximately 306 employees.